# Biorepository and Histopathology

> **NIH NIH P30** · RBHS -CANCER INSTITUTE OF NEW JERSEY · 2022 · $183,139

## Abstract

BIOSPECIMEN REPOSITORY AND HISTOLOGY SERVICE SHARED RESOURCE 
PROJECT SUMMARY/ABSTRACT 
The Biospecimen Repository and Histology Service shared resource (Biorepository) of the Rutgers Cancer 
Institute of New Jersey (CINJ) is a Cancer Center managed shared resource whose purpose is to support 
transdisciplinary and translational research through cost-effective, quality controlled tissue collection, 
biospecimen procurement and processing and cancer clinical trial support. 
The Biorepository provides tissues for cancer research through a seamless acquisition-processing-distribution 
pathway. The resource staff also provides collection, processing and shipping for thousands of clinical trial 
specimens by adhering to specific protocols. Our CLIA licensed histology laboratory delivers state of the art 
technologies for tissue analysis along with professional tissue examination by board-certified pathologists. The 
Biorepository follows best practices as dictated by the College of American Pathologists (CAP) guidelines. 
The Biorepository uses state of the art technologies for tissue analysis and professional interpretation under 
CAP guidelines. In addition, the Biorepository serves as an “honest broker” and maintains the chain of custody 
for patient samples and their clinical annotations. The Biorepository is comprised of three Divisions: 1) the 
Clinical Trial Laboratory, 2) the Banking Group and 3) the Histopathology Service. The Biorepository Lab 
Divisions support clinical trials, tissue banking and basic science by collecting, cataloging, processing, storing 
and distributing bio-specimens from human subjects while archiving useful medical information along with 
written patient consents. Each of the divisions is distinct, yet they cooperate to provide a seamless workflow 
and unparalleled service, and are operated by highly qualified technologists and strong leadership.

## Key facts

- **NIH application ID:** 10357804
- **Project number:** 5P30CA072720-23
- **Recipient organization:** RBHS -CANCER INSTITUTE OF NEW JERSEY
- **Principal Investigator:** GREGORY M RIEDLINGER
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $183,139
- **Award type:** 5
- **Project period:** 1997-03-01 → 2023-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10357804

## Citation

> US National Institutes of Health, RePORTER application 10357804, Biorepository and Histopathology (5P30CA072720-23). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10357804. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*